BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16257870)

  • 1. ASCOT - more than a horse race!
    Kjeldsen SE; Narkiewicz K; Hedner T
    Blood Press; 2005; 14(5):262-3. PubMed ID: 16257870
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcium channel blockers and cardiovascular complications in hypertensive diabetics.
    Hardy KJ; Flynn CA
    J Fam Pract; 1998 Jun; 46(6):454-5. PubMed ID: 9638103
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of treatment of hypertension on cardiovascular outcome in type 2 diabetes.
    Migdalis IN
    Res Commun Mol Pathol Pharmacol; 2006; 119(1-6):105-14. PubMed ID: 17974100
    [No Abstract]   [Full Text] [Related]  

  • 4. When hypertension and diabetes coexist: strategies for cardiorenal protection.
    Weber MA
    Postgrad Med; 2000 Oct; 108(5 Suppl):12-8. PubMed ID: 19667536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [HOMED-BP].
    Asayama K; Ohkubo T; Imai Y
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():459-64. PubMed ID: 16983777
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular risk in patients with type 2 diabetes.
    Shanks M; Holmes DT; Cermakova L; Frohlich J
    CMAJ; 2005 Apr; 172(9):1160-1. PubMed ID: 15851694
    [No Abstract]   [Full Text] [Related]  

  • 7. [ALLHAT].
    Ando K
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():402-7. PubMed ID: 16981570
    [No Abstract]   [Full Text] [Related]  

  • 8. ASCOT a four horse race.
    Sever P
    J Renin Angiotensin Aldosterone Syst; 2005 Sep; 6(2):51-4. PubMed ID: 16470483
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of cardiovascular ischemic events: high-risk and secondary prevention.
    Genest J; Pedersen TR
    Circulation; 2003 Apr; 107(15):2059-65. PubMed ID: 12707251
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of mortality rates in statin users versus nonstatin users in a United States veteran population.
    Mehta JL; Bursac Z; Hauer-Jensen M; Fort C; Fink LM
    Am J Cardiol; 2006 Oct; 98(7):923-8. PubMed ID: 16996875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypertension 2007-2008].
    Chatzikyrkou C; Menne J; Haller H
    Med Klin (Munich); 2009 Aug; 104(8):614-21. PubMed ID: 19701732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ASCOT trial: a closer look.
    Kaplan NM
    J Hypertens; 2006 Feb; 24(2):211-4. PubMed ID: 16508561
    [No Abstract]   [Full Text] [Related]  

  • 13. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Barzilay JI; Davis BR; Cutler JA; Pressel SL; Whelton PK; Basile J; Margolis KL; Ong ST; Sadler LS; Summerson J;
    Arch Intern Med; 2006 Nov; 166(20):2191-201. PubMed ID: 17101936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of microalbuminuria in type 2 diabetes. BENEDICT study].
    Nitschmann S
    Internist (Berl); 2006 Feb; 47(2):199-200; discussion 200. PubMed ID: 16416298
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of ASCOT on hypertension treatment and guidelines in older adults.
    Sheridan R; Baldwin N
    Age Ageing; 2006 May; 35(3):214-7. PubMed ID: 16638764
    [No Abstract]   [Full Text] [Related]  

  • 16. The importance of managing cardiovascular risk in the treatment of hypertension: the role of ACE inhibitors and ARBs.
    Pierson CA; Epstein BJ; Roberts ME
    J Am Acad Nurse Pract; 2008 Nov; 20(11):529-38. PubMed ID: 19128336
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker therapy to reduce cardiovascular events in high-risk patients: part 2.
    Bommer WJ
    Prev Cardiol; 2008; 11(4):215-22. PubMed ID: 19476574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety of antihypertensive therapy.
    Grossman E; Messerli FH
    Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.
    Kuti EL; Baker WL; White CM
    Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Need of tight blood pressure control in type 2 diabetes. The intervention study ADVANCE gives clear information].
    Nilsson PM
    Lakartidningen; 2007 Oct 17-23; 104(42):3028-9. PubMed ID: 17985709
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.